Broadfin Capital’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Hold |
0
| – | – | – | 59 |
|
|
2017
Q1 | – | Sell |
-3,370,306
| Closed | -$17.5M | – | 62 |
|
|
2016
Q4 | $17.5M | Hold |
3,370,306
| – | – | 1.94% | 15 |
|
|
2016
Q3 | $18.8M | Hold |
3,370,306
| – | – | 1.68% | 16 |
|
|
2016
Q2 | $18.7M | Buy |
3,370,306
+325,000
| +11% | +$1.8M | 1.82% | 14 |
|
|
2016
Q1 | $13.4M | Hold |
3,045,306
| – | – | 1.29% | 19 |
|
|
2015
Q4 | $18.3M | Buy |
3,045,306
+1,500,000
| +97% | +$9.03M | 1.13% | 18 |
|
|
2015
Q3 | $12.1M | Buy |
1,545,306
+431,406
| +39% | +$3.37M | 0.67% | 34 |
|
|
2015
Q2 | $6.83M | Buy |
1,113,900
+88,900
| +9% | +$545K | 0.37% | 55 |
|
|
2015
Q1 | $8.26M | Hold |
1,025,000
| – | – | 0.64% | 41 |
|
|
2014
Q4 | $5.19M | Buy |
+1,025,000
| New | +$5.19M | 0.45% | 50 |
|